Filing Details

Accession Number:
0001104659-25-003064
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-01-13 16:34:37
Reporting Period:
2025-01-10
Accepted Time:
2025-01-13 16:34:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1420720 Ibio Inc. IBIO Pharmaceutical Preparations (2834) 262797813
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1964267 Felipe Duran C/O Ibio, Inc.
11750 Sorrento Valley Road, Suite 200
San Diego CA 92121
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-01-10 9,191 $2.72 11,139 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Shares purchased by Reporting Person pursuant to a Securities Purchase Agreement with iBio, Inc., dated January 10, 2025.